AM
Publications
15
Views
8,087
Downloads
2,016
Supervised works
0
Items per page
1 - 15 of 15
Title Published in Access level OA Policy Year Views Downloads
Uncovering a Genetic Polymorphism Located in Huntingtin Associated Protein 1 in Modulation of Central Pain Sensitization Signaling PathwaysFrontiers in neuroscience
accessLevelPublic
2022 404 74
Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activityBritish journal of pharmacology
accessLevelPublic
2021 312 129
Exploration du rôle de la modulation GABAergique dans la transmission de la douleur chez l'homme : Effet du modulateur allostérique GABAA N-desméthylclobazam sur la sensibilisation centrale; étude pharmacodynamique et pharmacocinétique chez le volontaire sain
accessLevelPrivate
2021 322 2
GABAergic modulation of secondary hyperalgesia: A randomized controlled 4-way crossover trial with the α2-subunit preferring GABA positive allosteric modulator, N-desmethyl-clobazam in healthy volunteersEuropean Journal of Pain
accessLevelRestricted
2020 249 1
Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trialClinical Microbiology and Infection
accessLevelPublic
2020 318 167
Impact of CYP2D6 functional allelic variations on phenoconversion and drug-drug interactionsClinical Pharmacology and Therapeutics
accessLevelRestricted
2017 485 5
The clobazam metabolite N-desmethyl clobazam is an α2 preferring benzodiazepine with an improved therapeutic window for antihyperalgesiaNeuropharmacology
accessLevelPublic
2016 580 298
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe : Preliminary ReportThe New England journal of medicine
accessLevelPublic
2016 905 262
A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patientsMultiple sclerosis
accessLevelRestricted
2015 637 1
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trialLancet. Infectious diseases
accessLevelRestricted
2015 686 0
P-glycoprotein: a clue to vitamin K antagonist stabilizationPharmacogenomics
accessLevelRestricted
2015 691 0
A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - a twelve month follow-upJournal of neuroimmunology
accessLevelRestricted
2015 592 1
GABAergic modulation in central sensitization in humans: a randomized placebo-controlled pharmacokinetic-pharmacodynamic study comparing clobazam with clonazepam in healthy volunteersPain
accessLevelRestricted
2015 617 3
Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia patients: a randomized, double-blind, placebo-controlled trialPain physician
accessLevelPublic
2013 615 1,073
Impact of CYP2C9 polymorphisms on the vulnerability to pharmacokinetic drug-drug interactions during acenocoumarol treatmentPharmacogenomics
accessLevelRestricted
2013 674 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack